Literature DB >> 1700814

Mechanisms of potassium channel block in rat alveolar epithelial cells.

E R Jacobs1, T E DeCoursey.   

Abstract

Block of inactivating delayed rectifier K+ currents was studied in rat alveolar epithelial cells in primary culture using the whole-cell configuration of the gigohm-seal voltage-clamp technique. Charybdotoxin was the only blocker studied which did not alter K+ current kinetics; it produced a simple block (K1 approximately 1 nM) which appeared to be independent of voltage or channel state (open, closed or inactivated). Tetraethylammonium slowed inactivation of K+ currents, consistent with the notion that blocked channels cannot inactivate. Verapamil and methoxyverapamil produced time-, voltage- and concentration-dependent "inactivation" or block of open channels during depolarizing pulses, with negligible block of closed channels at negative holding potentials. Capsaicin, chlorpromazine, phencyclidine, quinidine and tetrahydroaminoacridine both increased the rate of inactivation and decreased the peak K+ current. These characteristics suggest that both open and closed channels can be blocked, but that open channels are blocked preferentially. Nifedipine, like most other blockers, increased the rate of K+ current decay, but, unlike other blockers, resulted in two distinct kinetic components of current decay under some conditions. Because nifedipine is uncharged, the voltage and time-dependence of its block cannot be ascribed to a traditional ionic blockade mechanism. Mechanisms of K+ channel block are compared with block of Ca++ channels by calcium "antagonists" and block of Na+ channels by local anesthetics. Interactions between gating kinetics and K+ channel blockade seem to be the rule rather than the exception.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700814

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  Mechanism of verapamil block of a neuronal delayed rectifier K channel: active form of the blocker and location of its binding domain.

Authors:  L Catacuzzeno; C Trequattrini; A Petris; F Franciolini
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Block of the lymphocyte K(+) channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation.

Authors:  R J Röbe; S Grissmer
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Temperature dependence of drug blockade of a calcium-dependent potassium channel in cultured hippocampal neurons.

Authors:  J G McLarnon; X P Wang
Journal:  Biophys J       Date:  1991-11       Impact factor: 4.033

4.  Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes.

Authors:  V Avdonin; E F Shibata; T Hoshi
Journal:  J Gen Physiol       Date:  1997-02       Impact factor: 4.086

5.  The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel.

Authors:  H Rauer; S Grissmer
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 6.  Voltage-activated hydrogen ion currents.

Authors:  T E DeCoursey; V V Cherny
Journal:  J Membr Biol       Date:  1994-09       Impact factor: 1.843

7.  Hydrogen ion currents in rat alveolar epithelial cells.

Authors:  T E DeCoursey
Journal:  Biophys J       Date:  1991-11       Impact factor: 4.033

8.  Selective phenylalkylamine block of I(Kr) over other K(+) currents in guinea-pig ventricular myocytes.

Authors:  S E Jones; S Missan; P Zhabyeyev; T F McDonald
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

9.  Veratridine blocks voltage-gated potassium current in human T lymphocytes and in mouse neuroblastoma cells.

Authors:  J A Verheugen; M Oortgiesen; H P Vijverberg
Journal:  J Membr Biol       Date:  1994-02       Impact factor: 1.843

10.  Verapamil- and state-dependent effect of 2-aminoethylmethanethiosulphonate (MTSEA) on hK(v)1.3 channels.

Authors:  Azadeh Nikouee; Malika Janbein; Stephan Grissmer
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.